Schedule 13D ownership disclosure

OncBioMune Pharmaceuticals, Inc

Security class unavailable · CUSIP: 68235A200

Event date: 2020-06-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
99.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-20-011198
Form type
SC 13D
Filer
Avant Diagnostics, Inc
CIK
CIK 1451929
Filed
Jun 15, 2020
Reporting period
Jun 05, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub